Instrument Inactif

Cours Advanced Cell Technology, Inc. OTC Bulletin Board

Actions

Cours en clôture OTC Bulletin Board Autres places de cotation
- ^USD	-

Ocata Therapeutics : Astellas Announces Results of Tender Offer to Acquire All Outstanding Shares of Ocata Therapeutics and Changes to Subsidiaries	10/02/16
Ocata Therapeutics : Astellas Extends Tender Offer to Acquire All Outstanding Shares of Ocata Therapeutics	22/01/16
Ocata Therapeutics : Reports the Publication of Data about the Generation of Corneal Endothelial Cells from Human Pluripotent Stem Cells	28/12/15
Ocata Therapeutics : Hemangio-derived Mesenchymal Cells Preserve Kidney Function and Extend Lifespan in Preclinical Model of Lupus Nephritis	03/12/15
OCATA THERAPEUTICS : Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Merger with Astellas Pharma Inc.	11/11/15

Dirigeants	Titre	Age	Depuis
Yoshitsuga Shitaka PSD	President	-	-
John Heffernan PRN	Corporate Officer/Principal	-	03/02/15

Administrateurs	Titre	Age	Depuis
Percival Barretto-Ko BRD	Director/Board Member	51	-
Masaaki Hirano BRD	Director/Board Member	57	-
Toru Yoshimitsu BRD	Director/Board Member	61	-

Secteur

	Varia. 1 janv.	Capi.
VERTEX PHARMACEUTICALS INCORPORATED	+4,42%	111 Md
REGENERON PHARMACEUTICALS, INC.	+10,95%	105 Md
BIONTECH SE	-12,01%	22,34 Md
ARGENX SE	-3,81%	21,93 Md
GENMAB A/S	-5,94%	18,59 Md
WUXI APPTEC CO., LTD.	-36,52%	18,12 Md
BEIGENE, LTD.	-10,04%	16,96 Md
NEUROCRINE BIOSCIENCES, INC.	+3,07%	13,7 Md
SAREPTA THERAPEUTICS, INC.	+37,10%	12,45 Md